Suchergebnisse - "Broome, Catherine M"

PubPharm (31)

1

COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab

enthalten in: American journal of hematology | 2024

von Fattizzo, B. | Röth, A. | Broome, C. | +4

2

The latest insights into rare blood disorders : Diagnosis and treatment strategies

enthalten in: American journal of hematology | 2024

von Kuter, D. | Cataland, S. | Broome, C. | +1

3

COVID‐19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab

enthalten in: American Journal of Hematology | 2024

von Fattizzo, B. | Röth, A. | Broome, C. | +4

4

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV) : a multicentre, randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Broome, C. | McDonald, V. | Miyakawa, Y. | +83

5

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease : CARDINAL 2-year follow-up

enthalten in: Blood advances | 2023

von Röth, A. | Broome, C. | Barcellini, W. | +10

6

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

enthalten in: Blood advances | 2023

von Ujjani, C. | Gooley, T. | Spurgeon, S. | +23

7

Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease

enthalten in: American journal of hematology | 2023

von Röth, A. | Barcellini, W. | D'Sa, S. | +15

8

Complement-directed therapy for cold agglutinin disease : sutimlimab

enthalten in: Expert review of hematology | 2023

von Broome, C.

9

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia

enthalten in: Blood advances | 2023

von Broome, C. | Röth, A. | Kuter, D. | +6

10

Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease : Results from the randomised, placebo-controlled, Phase 3 CADENZA study

enthalten in: European journal of haematology | 2023

von Röth, A. | Broome, C. | Barcellini, W. | +12